ReYou Ketamine Treatments

What ReYou Ketamine Treatments does

ReYou Ketamine Treatments, operating under the legal entity Make Life Better LLC, is a New Jersey-based outpatient mental health clinic that administers Spravato (esketamine) and IV ketamine therapy for treatment-resistant depression, anxiety, PTSD, OCD, postpartum depression, suicidal ideation, and addiction. The clinic runs two locations — Howell Township (5170 Route 9 South) and South Plainfield (908 Oak Tree Ave, Suite M) — operating Monday through Friday 10am–8pm, and also offers a home-delivery service called Reyou-to-You in which a trained integrator brings medical-grade vitals monitoring, curated music, and the Reyou Method to the patient's residence with prescribed oral or sublingual ketamine. All clinical health information is handled under HIPAA-compliant systems.

The core technology is the proprietary Reyou Method integration protocol, which combines pre-session intention-setting, neuroscience-tailored WavePaths music playlists, set-and-setting mastery, and post-session therapeutic processing to translate pharmacological effects into durable clinical outcomes. Treatments are delivered in private sanctuary rooms with recliners, weighted blankets, and noise-canceling headphones, supported by a specialized clinical team that includes IPI-certified psychiatrists, ketamine-trained physicians, an on-staff trauma therapist, and a mindfulness/meditation expert. The clinic accepts major insurance plans — including NJ Family Care, Horizon, and Empire — for Spravato coverage, while IV ketamine is paid out-of-pocket with financing available.

ReYou's go-to-market combines direct consumer consultations, an extensive educational blog, social media presence on Facebook, Instagram, and LinkedIn, and a formal therapist/provider referral network. Revenue mechanics are split between insurance-billed Spravato sessions (monthly recurring) and out-of-pocket ketamine infusions (pay-as-you-go), with no disclosed external institutional funding, M&A activity, or public-market signals. The company is privately held under Make Life Better LLC and operates entirely within New Jersey.

Name

ReYou Ketamine Treatments

Legal name

Make Life Better LLC

Website

https://reyou.life

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

ReYou Ketamine Treatments (Make Life Better LLC) is a New Jersey outpatient mental health clinic operating two locations in Howell Township and South Plainfield that administers Spravato and IV ketamine therapy for treatment-resistant depression, anxiety, PTSD, OCD, and addiction, with an at-home delivery option also offered.

Ownership category

akta.pro rank

Product category

Specialty Mental Health Treatment Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (62142)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD)

akta.pro secondary industry

Substance Use Recovery & Harm Reduction Support Services (BPAGAEAO)

Keywords

• Ketamine infusion therapy
• Esketamine depression treatment
• Mental health clinic
• Spravato nasal therapy
• Treatment resistant depression

Headquarters

HQ city

Howell

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Spravato Treatment: FDA-approved Spravato (esketamine) nasal spray for treatment-resistant depression and suicidal ideation. This treatment is covered by most major insurance plans including NJ Family Care, Horizon, and Empire plans, subject to eligibility and authorization. The clinic handles insurance paperwork and benefits verification.
2. Ketamine Therapy: IV ketamine infusion therapy for depression, anxiety, PTSD, OCD, addiction, and other conditions. Since ketamine is prescribed off-label for mental health, it is typically not covered by insurance and patients pay out-of-pocket. Financing options are available.
3. At-Home Ketamine Treatment: Reyou-to-You home treatment option where a trained integrator delivers medical-grade vitals monitoring, curated music, and the full Reyou Method to the patient's home. Oral or sublingual ketamine lozenges may be prescribed.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

ReYou Ketamine Treatments is a New Jersey mental-health clinic that administers FDA-approved Spravato (esketamine) nasal spray therapy and medically supervised IV ketamine infusions for treatment-resistant depression, anxiety, PTSD, OCD, postpartum depression, suicidal ideation, and addiction. Treatments are delivered in private clinic rooms or via the Reyou-to-You at-home service, supported by a proprietary Reyou Method integration program that combines pre-session intention-setting, neuroscience-tailored music, and post-session therapeutic integration.

Product overview

ReYou Ketamine Treatments operates as a mental health treatment clinic offering two FDA-approved ketamine-based therapies: Spravato® (esketamine) and IV Ketamine Therapy. Spravato® is an FDA-approved nasal spray for treatment-resistant depression and suicidal ideation, typically covered by insurance. Ketamine Therapy is an IV infusion treatment for broader conditions including depression, anxiety, PTSD, OCD, addiction, and postpartum depression. The company also offers 'Reyou-to-You' for at-home treatment delivery. All treatments are delivered through 'The Reyou Experience' methodology, a proprietary care framework emphasizing pre/post-session integration, neuroscience-tailored music, and a sanctuary treatment environment.

Differentiator

Problem solved

Functional benefit

Products and services

• Spravato Therapy FDA-approved esketamine nasal spray administered on-site under medical supervision for treatment-resistant depression and suicidal ideation; typically covered by major insurance plans (NJ Family Care, Horizon, Empire) with benefits verification handled by the clinic.
• Ketamine Therapy (IV Infusion) Medically supervised IV ketamine infusion therapy for depression, anxiety, PTSD, OCD, addiction, postpartum depression, and other conditions; prescribed off-label, generally paid out-of-pocket, with personalized dosing and pre/post integration support.
• Reyou-to-You (At-Home Treatment) At-home treatment delivery service where a trained integrator brings medical-grade vitals monitoring, curated music, and the full Reyou Method to the patient; oral/sublingual ketamine lozenges may be prescribed, with no unsupervised dosing.
• The Reyou Experience Proprietary care methodology that wraps Spravato and ketamine therapy in a sanctuary treatment environment with intention-setting, neuroscience-tailored music, therapeutic integration every session, and structured pre/post-session support to translate insights into lasting change.

Quantifiable outcome

• 80% of veterans with comorbid PTSD and treatment-resistant depression achieved remission from PTSD; 93% achieved remission from depression after six ketamine infusions in clinical trial
• +2 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Talkiatry: Talkiatry is an in-network psychiatry practice providing medication management and psychiatric care via telehealth and in-person. It serves as both a potential referral source for Reyou and a competitor for patients seeking psychiatric treatment of depression and anxiety.
• Cerebral: Cerebral is a broader telehealth mental health platform providing therapy and medication management for depression and anxiety. It competes for the same patient demand Reyou serves, though its core offering is conventional pharmacotherapy rather than ketamine.
• Lyra Health: Lyra Health is an enterprise mental health benefits platform offering therapy, coaching, and medication management. It overlaps with Reyou's target patient population (working adults with depression/anxiety) and serves as a potential referral source or competitor depending on payer mix.
• Charlie Health: Charlie Health is a larger virtual mental health provider focused on intensive outpatient programs for adolescents and young adults. While broader in scope than Reyou, it overlaps on treatment-resistant mental health conditions and uses adjunctive pharmacological and therapeutic approaches.
• Brightside Health: Brightside Health is a telehealth mental health provider combining therapy and medication for depression and anxiety. While not offering ketamine directly, it competes for the same treatment-resistant patient segment Reyou targets.

Direct peers

• Mindbloom: Mindbloom operates at-home ketamine therapy with medical supervision and integration support, overlapping Reyou-to-You. Both target treatment-resistant mental health conditions through guided ketamine experiences with telehealth-enabled oversight.
• Nue Life: Nue Life offers at-home ketamine therapy programs with medical monitoring and integration support, directly comparable to Reyou-to-You. Both target adults with treatment-resistant depression and anxiety through guided, tech-enabled ketamine experiences.
• Stella Mental Health: Stella Mental Health operates clinics offering Spravato and ketamine therapy with integration support, directly paralleling Reyou's clinic-based model. Both treat depression, anxiety, PTSD, and other mental health conditions via ketamine-based protocols under medical supervision.
• Journey Clinical: Journey Clinical provides ketamine-assisted therapy via telehealth with a provider network, comparable to Reyou's ketamine therapy offering. Both emphasize clinician-supervised ketamine protocols and integration support for treatment-resistant conditions.
• Klarity: Klarity is a ketamine therapy provider delivering at-home and clinic-based treatments for depression, anxiety, and PTSD. The model overlaps Reyou's ketamine and Reyou-to-You service lines with similar patient segments and indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/reyou.life
• LinkedInlinkedin.com/company/reyou-ketamine-treatments
• Instagraminstagram.com/reyouyourlife

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ReYou Ketamine Treatments